Osimertinib for patients (pts) with leptomeningeal metastases (LM) associated with EGFRm advanced NSCLC: The AURA LM study
Title:
Osimertinib for patients (pts) with leptomeningeal metastases (LM) associated with EGFRm advanced NSCLC: The AURA LM study
Author:
Ahn, M.-J. Chiu, C.-H. Cheng, Y. Han, J.-Y. Goldberg, S.B. Greystoke, A. Crawford, J. Zhao, Y. Huang, X. Johnson, M. Vishwanathan, K. Mendoza-Naranjo, A. Mok, T.S.K.